A Study of Imatinib and Nilotinib in Patients With Chronic Myelogenous Leukemia in Chronic Phase
Clinical trial NCT02272777 · COMPLETED
Trial details
- NCT number
- NCT02272777
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-17
- Primary completion
- 2017-01-30
- Enrollment
- 225
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.